SMTL ID : 4ogn.1

Co-Crystal Structure of MDM2 with Inhbitor Compound 3

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.38 Å

Oligo State

monomer

Ligands

1 x 2U5: 6-{[(3R,5R,6S)-1-[(1S)-2-(tert-butylsulfonyl)-1-cyclopropylethyl]-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl]methyl}pyridine-3-carboxylic acid(Non-covalent)

2U5.1: 14 residues within 4Å: Chain A: V.9, T.10, T.11, Q.13, L.49, L.52, I.56, M.57, Y.62, V.88, K.89, H.91, I.94, Y.95 10 PLIP interactions: 10 interactions with chain A Hydrophobic interactions: A:V.9, A:T.11, A:I.56, A:Y.62, A:V.88, A:K.89 Hydrogen bonds: A:Q.13 Salt bridges: A:K.89 pi-Stacking: A:H.91 Halogen bonds: A:H.91

2 x SO4: SULFATE ION(Non-functional Binders)

SO4.2: 2 residues within 4Å: Chain A: Q.66, H.68 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:Q.66 Salt bridges: A:H.68 SO4.3: 2 residues within 4Å: Chain A: P.15, A.16 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:A.16 Water bridges: A:S.17

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Gonzalez, A.Z. et al., Novel Inhibitors of the MDM2-p53 Interaction Featuring Hydrogen Bond Acceptors as Carboxylic Acid Isosteres. J.Med.Chem. (2014)

Release Date

2014-04-02

Peptides

E3 ubiquitin-protein ligase Mdm2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

E3 ubiquitin-protein ligase Mdm2

Related Entries With Identical Sequence